No headlines found.
Streamline Health To Report Fiscal Third Quarter 2024 Financial Performance
Globe Newswire (Mon, 9-Dec 5:15 PM ET)
Streamline Health Announces New eValuator Contract With Texas-Based Health System
Globe Newswire (Tue, 5-Nov 7:30 AM ET)
Streamline Health Adds Quality Module to Third eValuator Client
Globe Newswire (Tue, 29-Oct 7:30 AM ET)
Streamline Health Adds Quality Module to Existing eValuator Relationship
Globe Newswire (Wed, 23-Oct 7:30 AM ET)
Streamline Health Debuts eValuator Quality Module
Globe Newswire (Tue, 8-Oct 7:30 AM ET)
Streamline Health Announces 1-For-15 Reverse Stock Split
Globe Newswire (Thu, 26-Sep 5:18 PM ET)
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
Streamline Health Solns trades on the NASDAQ stock market under the symbol STRM.
As of December 13, 2024, STRM stock price climbed to $3.50 with 51,496 million shares trading.
STRM has a beta of 0.03, meaning it tends to be less sensitive to market movements. STRM has a correlation of 0.00 to the broad based SPY ETF.
STRM has a market cap of $14.78 million. This is considered a Sub-Micro Cap stock.
Last quarter Streamline Health Solns reported $4 million in Revenue and -$.75 earnings per share. This beat revenue expectation by $146,000 and missed earnings estimates by -$.15.
In the last 3 years, STRM traded as high as $35.25 and as low as $1.85.
The top ETF exchange traded funds that STRM belongs to (by Net Assets): VTI, VXF, DFAT.
STRM has underperformed the market in the last year with a return of -33.3%, while the SPY ETF gained +29.9%. In the last 3 month period, STRM fell short of the market, returning +6.5%, while SPY returned +7.8%. However, in the most recent 2 weeks STRM has outperformed the stock market by returning +33.6%, while SPY returned +0.3%.
STRM support price is $3.02 and resistance is $3.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STRM shares will trade within this expected range on the day.